An increasing number of pharma companies are relying on bioanalytic measurements. What are the roles of novel techniques such as LC or MS in drug development, and how are biomarkers used? Michael Lindenmaier compiled an extensive list of biomarkers across various therapeutic areas. In addition, he takes a closer look on bioanalytic offerings by providers in Eastern Europe and Asia.